CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)

456 participants · First posted May 8, 2013

INFUSE Morphine Study

13 participants · First posted Jan 14, 2008

Descriptive Study of Cardiac Output During Rehydration With Recombinant Human Hyaluronidase in Pediatrics

17 participants · First posted Jun 8, 2010

RUTI® Vaccine

X-Synergy®

GENOMIC HEALTH, INC.

United States

Theralase Technologies Inc

Canada

Zymenex A/S

Denmark

Merus and Halozyme Partner to Develop Subcutaneous Formulation of Petosemtamab for Cancer Treatment

Huonslab Submits Biologics License Application for Recombinant Human Hyaluronidase HYDIZYME™

ViroGates and Sobi Expand Collaboration on suPARnostic® Diagnostic for Kineret® Treatment